首页 | 本学科首页   官方微博 | 高级检索  
     


Pilot study of intravenous melphalan combined with continuous infusion L‐S,R‐buthionine sulfoximine for children with recurrent neuroblastoma
Authors:Clarke P. Anderson MD  Katherine K. Matthay MD  John P. Perentesis MD  Joseph P. Neglia MD  MPH  Howard H. Bailey MD  Judith G. Villablanca MD  Susan Groshen PhD  Beth Hasenauer MS  RN  John M. Maris MD  Robert C. Seeger MD  C. Patrick Reynolds MD  PhD
Affiliation:1. City of Hope National Medical Center, Department of Pediatrics, Duarte, California;2. Department of Pediatrics, University of California School of Medicine, San Francisco, California;3. Division of Hematology/Oncology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio;4. Department of Pediatrics, University of Minnesota Medical School, Minneapolis, Minnesota;5. Department of Medicine, University of Wisconsin Comprehensive Cancer Center, Madison, Wisconsin;6. Division of Hematology‐Oncology, Department of Pediatrics, Children's Hospital Los Angeles, Los Angeles, California;7. Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California;8. Division of Oncology, Children's Hospital of Philadelphia, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania;9. Cancer Center and Departments of Cell Biology & Biochemistry, Pediatrics and Medicine, School of Medicine, Texas Tech University Health Sciences Center, Lubbock, Texas
Abstract:
Keywords:glutathione  melphalan  neuroblastoma  reactive oxygen species
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号